| 摘要 |
FIELD: biotechnology, medicine. SUBSTANCE: live vaccine has the following components, vol.%: strain L-16v (GKV N 2277) taken in an infecting dose 0.2 <EMI ID=0.143 HE=3 WI=3 TI=CHI> 0.1 TCD<SB>50</SB>/cell; aminopeptide 5-8; Eagle medium or Eagle MEM 92-95 medium and a stabilizing agent - the rest. Vaccine shows the enhanced immunogenic activity and provides a possibility of intranasal administration and vaccination of children of age younger 9 months. EFFECT: enhanced effectiveness of vaccine. 6 tbl, 7 ex
|
